Anosmia Market Report 2026

Anosmia Market Overview

• Anosmia market size has reached to $3.86 billion in 2025 • Expected to grow to $6.07 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Impact Of Rising Neurological Disorders On The Growth Of The Anosmia Market • Market Trend: Innovations In Soft-Mist Nasal Spray Technology Enhance Targeted Therapeutics In Anosmia • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anosmia Market?

Anosmia is a medical term that refers to the complete or partial loss of the sense of smell. It can occur due to various factors affecting the olfactory system, including nasal congestion, nasal polyps, neurological disorders, head trauma, viral infections, and exposure to certain chemicals or medications. Anosmia can be temporary or permanent and may affect one or both nostrils. It often reduces the ability to detect or identify odors, impacting the individual's sense of taste and overall quality of life. The main types in the anosmia market are idiopathic anosmia and congenital anosmia. Idiopathic anosmia refers to the loss of the sense of smell with no identifiable cause, even after thorough medical evaluation and diagnostic testing. The various treatments include therapies and medications, several end users including hospitals, clinics, and others.

What Is The Anosmia Market Growth Forecast?

The anosmia market size is expected to see strong growth in the next few years. It will grow to $6.07 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rising research into olfactory nerve regeneration, growing adoption of novel therapies, expansion of post-infectious care programs, increasing demand for quality-of-life treatments, growing clinical trial activity. Major trends in the forecast period include increasing focus on regenerative therapies, rising use of smell training programs, growing adoption of targeted pharmacological treatments, expansion of diagnostic imaging and testing, enhanced emphasis on post-viral recovery management.

Global Anosmia Market Segmentation

1) By Type: Idiopathic Anosmia, Congenital Anosmia 2) By Treatment: Therapies, Medications 3) By End User: Hospitals, Clinics, Other End Users Subsegments: 1) By Idiopathic Anosmia: Partial Idiopathic Anosmia, Complete Idiopathic Anosmia 2) By Congenital Anosmia: Isolated Congenital Anosmia, Syndromic Congenital Anosmia (Associated With Other Conditions Or Syndromes)

What Is The Driver Of The Anosmia Market?

The rising incidence of neurological disorders is expected to propel the growth of the anosmia market going forward. Neurological disorders encompass a broad range of conditions that affect the nervous system, including the brain, spinal cord, and nerves throughout the body. The rising incidence of neurological disorders is due to an aging population and the increased prevalence of chronic diseases such as diabetes and hypertension. Neurological disorders can cause anosmia by damaging the olfactory pathways or regions in the brain responsible for processing smell, leading to a loss of the ability to detect or perceive odors. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization, 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, with projections indicating this could rise to 13.8 million by 2060. Thus, the rising incidence of neurological disorders is driving the growth of the anosmia industry.

Key Players In The Global Anosmia Market

Major companies operating in the anosmia market are Cyrano Therapeutics, Regeneron Pharmaceuticals, Novartis AG, GlaxoSmithKline PLC, Otsuka Pharmaceutical Co Ltd, Bayer AG, AstraZeneca PLC, Eli Lilly and Company, Pfizer Inc, Sanofi SA, NeuroNascent Inc, Immunome Therapeutics, Olfactory Therapeutics Ltd, ENT Therapeutics Inc, NeuroSense Therapeutics LLC, SmellSense Bio, Olfactricity Therapeutics, Sensory Neurogenics Inc, Olfaxion Biotech, SmellGen Therapeutics, Post‑Viral Sensory Recovery Inc, Hyposmia Therapeutics LLC

Global Anosmia Market Trends and Insights

Major companies operating in the anosmia market are focusing on developing advanced delivery systems, such as soft-mist nasal sprays, to enhance efficacy, improve drug absorption, and target the olfactory region more precisely. Soft-mist nasal spray technology uses controlled droplet size and low spray velocity to maximize deposition in the olfactory region, thereby increasing therapeutic effect. For instance, in April 2025, Cyrano Therapeutics, a U.S.-based clinical-stage regenerative medicine company, completed enrollment in the Phase 2 FLAVOR trial of its soft-mist nasal spray candidate, CYR-064, for post-viral smell loss. The product features a patent-protected intranasal formulation of a broad-spectrum phosphodiesterase (PDE) inhibitor designed to boost olfactory neuron excitability, and, by using the Ursatec 3K pump system combined with Resyca’s soft-mist spray technology, it achieves precise and targeted deposition into the olfactory region.

What Are Latest Mergers And Acquisitions In The Anosmia Market?

In November 2023, Fifth Sense, a UK-based charity organization, partnered with ENT UK to improve care for people affected by smell and taste disorders. With this partnership, these organizations aim to focus on supporting patients and healthcare professionals with smell and taste disorders, including anosmia. ENT UK is a UK-based professional membership body representing ear, nose, and throat surgery.

Regional Outlook

North America was the largest region in the anosmia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Anosmia Market?

The anosmia market consists of revenues earned by entities by providing services such as olfactory testing and imaging, medical consultations, therapeutic services, medication management, rehabilitative services including psychological support and nutritional counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The anosmia market also includes sales of diagnostic tools, medical devices, and nasal sprays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anosmia Market Report 2026?

The anosmia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anosmia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.